13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001549408
Total reported value
$241.4M
$241.4M
13 檔
79.4%
During the Q1 2026 filing period, Alethea Capital Management, LLC (CIK: 0001549408) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $241.4M across 13 reported positions.
Alethea Capital Management, LLC executed strategic sector rebalancing during Q1 2026, establishing 3 new positions while fully exiting 3 holdings and trimming 3 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 56.28% | +9.50% | -2.93% | |
| 2 | BIL | Ss Spdr Bb 1-3m T-bill ETF | ETF-Gov Bonds | 30.09% | -17.77% | +170.50% | |
| 3 | KURA | Kura Oncology Inc | Stock-Other | 6.38% | +3.47% | +7.50% | |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 4.57% | -4.57% | EXIT | |
| 5 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 1.02% | -0.26% | -1.26% | |
| 6 | TEM | Tempus Ai Inc-cl A | Stock-Healthcare | 0.73% | +0.03% | — | |
| 7 | RNA | Atrium Therapeutics Inc | Stock-Other | 0.30% | -0.06% | — | |
| 8 | WFC | Wells Fargo & Co | Stock-Financials | 0.25% | -0.04% | — | |
| 9 | HEDJ | Wisdomtree Europe Hedged Equ | ETF-Other | 0.20% | -0.03% | — | |
| 10 | GPK | Graphic Packaging Holding Co | Stock-Consumer Disc | 0.08% | -0.01% | — | |
| 11 | IMRX | Immuneering CORP - Class A | Stock-Other | 0.06% | +0.92% | — | |
| 12 | TGB | Taseko Mines LTD | Stock-Other | 0.03% | -0.03% | EXIT | |
| 13 | LPRO | Open Lending CORP | Stock-Other | 0.01% | +0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BIL | Ss Spdr Bb 1-3m T-bill ETF | +19.6% | +170.50% | Add |
| 2 | TLT | Ishares 20+ Year Treasury Bd | 0% | -1.26% | Trim |
| 3 | HEDJ | Wisdomtree Europe Hedged Equ | 0% | — | Unchanged |
| 4 | TGB | Taseko Mines LTD | — | — | Unchanged |
| 5 | LPRO | Open Lending CORP | — | — | Unchanged |
| 6 | IMRX | Immuneering CORP - Class A | 0% | — | Unchanged |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | 0% | -1.70% | Trim |
| 8 | TEM | Tempus Ai Inc-cl A | -0.2% | — | Unchanged |
| 9 | KURA | Kura Oncology Inc | -0.8% | +7.50% | Add |
| 10 | AXSM | Axsome Therapeutics Inc | -3% | -2.93% | Trim |
| 11 | RNAGBP | Avidity Biosciences Inc | — | EXIT | Sold out |
| 12 | CDTX | Cidara Therapeutics Inc | — | EXIT | Sold out |
| 13 | RNA | Atrium Therapeutics Inc | — | NEW | New buy |
| 14 | WFC | Wells Fargo & Co | — | NEW | New buy |
| 15 | RSPU | Invesco S&p 500 Equal Weight | — | EXIT | Sold out |
| 16 | GPK | Graphic Packaging Holding Co | — | NEW | New buy |
According to official SEC Form 13F filings, Alethea Capital Management, LLC reported a total U.S. public equity portfolio value of $241.4M across 13 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including AXSM, BIL, KURA) accounted for 79.4% of total reported equity market value during Q1 2026.
Top New Position Initiated
RNA
市值: $585.0K
Top Position Liquidated / Trimmed
RNAGBP
前期市值: $32.2M
During Q1 2026, Alethea Capital Management, LLC's top holdings by market value included AXSM (56.3%)、BIL (30.1%)、KURA (6.4%). The largest single position, AXSM, represented 56.3% of total portfolio value.
In Q1 2026, Alethea Capital Management, LLC made 11 total portfolio adjustments, initiating 3 new buys, adding to 2 positions, trimming 3 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.